- ►prsjournal.net J Ioannidis - Epidemiology, 2008 - journals.lww.com From the Department of Hygiene and Epidemiology, University of Ioannina School of Medicine,
Ioannina, Greece; and Department of Medicine, Tufts University School of Medicine, Boston,
Massachusetts. Cited by 48 - Related articles - All 7 versions
- ►ascopubs.org [PDF] T Powles, D Robinson, J Stebbing, J … - Journal of Clinical …, 2008 - jco.ascopubs.org Eray Goekkurt, Salah-Eddin Al-Batran, Jörg T. Hartmann, Ulrike Mogck, Gunter Schuch, Michael
Kramer, Elke Jaeger, Carsten Bokemeyer, Gerhard Ehninger, and Jan Stoehlmacher From the Department
of Internal Medi- cine I, ... Cited by 13 - Related articles - All 4 versions
- ►ascopubs.org [PDF] EL Korn, B Freidlin, M Mooney - Journal of Clinical Oncology, 2009 - jco.ascopubs.org Edward L. Korn, Boris Freidlin, and Margaret Mooney From the Biometric Research Branch and the
Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and
Diag- nosis, National Cancer ... Cited by 6 - Related articles - All 6 versions
PM Ridker - Circulation: Cardiovascular Quality and Outcomes, 2009 - Am Heart Assoc Statin therapy is effective at reducing cardiovascular event rates among those with prior myocardial
infraction, stroke, diabetes, or overt hyperlipidemia, and current guidelines strongly recommend
lipid-lowering therapy among these ... Cited by 7 - Related articles
B Freidlin, EL Korn - Clinical Trials, 2009 - ctj.sagepub.com Background It has been suggested in the literature that the well-known bias of treatment-effect
estimators due to the possibility of early stopping for positive results is a major concern with
interim monitoring. Purpose To ... Cited by 4 - Related articles - All 2 versions
SN Goodman - Journal of Clinical Epidemiology, 2008 - Elsevier This comment is made based on simulations where 100% of trials used in a meta-analysis use a
stopping rule (the same rule) that would maximally amplify any effect of such trials. What they mean
by “approximate unbiasedness” ... Cited by 5 - Related articles - All 6 versions
AE Shamoo, LI Katzel - Clinical Pharmacology & Therapeutics, 2008 - nature.com Research with human subjects, including clinical trials, forms the cornerstone of the development of
knowledge on the safety and efficacy of potential drugs and devices. During the conduct of clinical
trials, human subjects may ... Cited by 1 - Related articles - All 4 versions
- ►biolreprod.org [PDF] G Cavallini, A Crippa, MC Magli, N Cavallini, … - Biology of …, 2008 - Soc Study Reprod Page 1. 1 TITLE. A study to sustain the hypothesis of the multiple genesis of
oligoasthenoteratospermia in 1 human idiopathic infertile males. 2 3 Running Title.
Idiopathic oligoasthenoteratospermia: a mosaic? 4 5 Giorgio Cavallini 1 , Andor ... Cited by 1 - Related articles - All 4 versions
RJ Gibbons, A Fugh-Berman, PS Chan, BK … - New England Journal …, 2009 - content.nejm.org To the Editor: Ridker et al. (Nov. 20 issue) re- port the results of Justification for the Use of
Stat- ins in Prevention: an Intervention Trial Evaluat- ing Rosuvastatin (JUPITER), 1 which showed
that rosuvastatin significantly ... Cited by 1 - Related articles - All 3 versions
